SAN DIEGO, Jan. 11, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") and COLA, a private, non-profit clinical laboratory education, consultation and ...

SAN DIEGO, May 12, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) announced today that it has received approval for the TearLab Osmolarity System from the Agência ...

SAN DIEGO, July 21, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) today announced that the commercial version of its next-generation in-vitro diagnostics testing ...

SAN DIEGO, Aug. 31, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) today announced that it has entered into a cooperative marketing agreement with Abbott Medical Optics Inc.'s ...

SAN DIEGO, Oct. 19, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) announced today that, further to its press release of October 8, 2010, a unique new Current Procedural ...

The company’s current osmolarity testing has been used over 24 million times, with primary growth driven in cornea and premium cataract/refractive practices Trukera Medical is positioned to expand its ...

The FDA granted a Clinical Laboratory Improvement Amendments to TearLab to widen the use of its Osmolarity System, a test for dry eye, according to a Reuter’s report. The change came after the device ...

* Tearlab Corp says it has elected to pursue initial U.S. FDA clearance of a test card measuring a single inflammatory biomarker, MMP-9, in combination with co's osmolarity test * Tearlab - ‍ elected ...

Ophthalmic diagnostic company TearLab announced it will change its name to Trukera Medical in an attempt to rebrand its vision and growth strategy. TearLab first entered the diagnostic market in 2010 ...

MiniFAB, a specialist in microtechnology and microfluidics, developed the osmolarity test card for the MDEA-winning TearLab system. When it comes to manufacturing miniature medical devices, design and ...

(Reuters) - TearLab Corp said U.S. health regulators granted a waiver that allowed for the wider use of its device to diagnose dry eye, sending the medical device maker's shares up as much as 80 ...